CLINICAL IMPACT OF DRUG-DRUG INTERACTIONS: CONSIDERATION OF ETHNIC AND OTHER PATIENT FACTORS

被引:0
|
作者
Huang, Shiew Mei [1 ]
机构
[1] US FDA, CDER, Off Clin Pharmacol, Silver Spring, MD USA
关键词
D O I
10.3109/03602532.2015.1071938
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
SC1.3
引用
收藏
页码:7 / 7
页数:1
相关论文
共 50 条
  • [21] Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly
    Juarez-Cedillo, Teresa
    Martinez-Hernandez, Cynthia
    Hernandez-Constantino, Angel
    Carlos Garcia-Cruz, Juan
    Avalos-Mejia, Annia M.
    Sanchez-Hurtado, Luis A.
    Islas Perez, Valentin
    Hansten, Philip D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (04) : 298 - 305
  • [22] The clinical pharmacist as a detective tracing drug-drug interactions
    De Winter, S.
    Decoutere, L.
    Deman, H.
    Spriet, I.
    Willems, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 246 - 246
  • [23] Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug-Drug Interactions
    Kiang, Tony K. L.
    Wilby, Kyle J.
    Ensom, Mary H. H.
    CLINICAL PHARMACOKINETICS, 2013, 52 (07) : 487 - 510
  • [24] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Vazquez, Marta
    Garcia-Carnelli, Carlos
    Maldonado, Cecilia
    Fagiolino, Pietro
    CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 : 27 - 42
  • [25] UDP-glucuronosyltransferases and clinical drug-drug interactions
    Kiang, TKL
    Ensom, MHH
    Chang, TKH
    PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) : 97 - 132
  • [26] Clinical Pharmacokinetics and Drug-Drug Interactions of Elbasvir/Grazoprevir
    Kiang, Tony K. L.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (05) : 509 - 531
  • [27] Mechanisms and the clinical relevance of complex drug-drug interactions
    Roberts, Arthur G.
    Gibbs, Morgan E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 123 - 134
  • [28] DRUG INTERACTIONS - CLINICAL SIGNIFICANCE OF DRUG-DRUG INTERACTIONS AND DRUG EFFECTS ON CLINICAL LABORATORY RESULTS - HANSTEN,PD
    BRILL, H
    AMERICAN JOURNAL OF PSYCHIATRY, 1977, 134 (11): : 1319 - 1320
  • [29] Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
    Ferri, Nicola
    Colombo, Elisa
    Corsini, Alberto
    HEMATOLOGY REPORTS, 2024, 16 (01) : 151 - 163
  • [30] Generating Evidence of Clinical Outcomes of Drug-Drug Interactions
    Bykov, Katsiaryna
    Gagne, Joshua J.
    DRUG SAFETY, 2017, 40 (02) : 101 - 103